Product Code: ETC5359080 | Publication Date: Nov 2023 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Taiwan Buprenorphine Market Overview |
3.1 Taiwan Country Macro Economic Indicators |
3.2 Taiwan Buprenorphine Market Revenues & Volume, 2021 & 2031F |
3.3 Taiwan Buprenorphine Market - Industry Life Cycle |
3.4 Taiwan Buprenorphine Market - Porter's Five Forces |
3.5 Taiwan Buprenorphine Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.6 Taiwan Buprenorphine Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 Taiwan Buprenorphine Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Taiwan Buprenorphine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the benefits of buprenorphine in managing opioid addiction |
4.2.2 Rising prevalence of opioid use disorders in Taiwan |
4.2.3 Government initiatives to improve access to buprenorphine treatment |
4.3 Market Restraints |
4.3.1 Stringent regulations and restrictions on the use of buprenorphine |
4.3.2 Stigma associated with medication-assisted treatment for opioid addiction |
4.3.3 Limited availability of healthcare professionals trained in prescribing buprenorphine |
5 Taiwan Buprenorphine Market Trends |
6 Taiwan Buprenorphine Market Segmentations |
6.1 Taiwan Buprenorphine Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 Taiwan Buprenorphine Market Revenues & Volume, By Analgesic, 2021-2031F |
6.1.3 Taiwan Buprenorphine Market Revenues & Volume, By Opioid Antagonist, 2021-2031F |
6.2 Taiwan Buprenorphine Market, By Route of Administration |
6.2.1 Overview and Analysis | 6.2.2 Taiwan Buprenorphine Market Revenues & Volume, By Injectables, 2021-2031F |
6.2.3 Taiwan Buprenorphine Market Revenues & Volume, By Sublingual, 2021-2031F |
6.2.4 Taiwan Buprenorphine Market Revenues & Volume, By Transdermal Patches, 2021-2031F |
6.3 Taiwan Buprenorphine Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Taiwan Buprenorphine Market Revenues & Volume, By Hospital Pharmacies, 2021-2031F |
6.3.3 Taiwan Buprenorphine Market Revenues & Volume, By Retail Pharmacies, 2021-2031F |
6.3.4 Taiwan Buprenorphine Market Revenues & Volume, By Online Pharmacies, 2021-2031F |
7 Taiwan Buprenorphine Market Import-Export Trade Statistics |
7.1 Taiwan Buprenorphine Market Export to Major Countries |
7.2 Taiwan Buprenorphine Market Imports from Major Countries |
8 Taiwan Buprenorphine Market Key Performance Indicators |
8.1 Number of healthcare facilities offering buprenorphine treatment |
8.2 Percentage of opioid addiction cases being treated with buprenorphine |
8.3 Patient adherence rates to buprenorphine treatment plan |
9 Taiwan Buprenorphine Market - Opportunity Assessment |
9.1 Taiwan Buprenorphine Market Opportunity Assessment, By Application, 2021 & 2031F |
9.2 Taiwan Buprenorphine Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 Taiwan Buprenorphine Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Taiwan Buprenorphine Market - Competitive Landscape |
10.1 Taiwan Buprenorphine Market Revenue Share, By Companies, 2024 |
10.2 Taiwan Buprenorphine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |